Artialis: Passion for Healthy Aging
Artialis, a leading Contract Research Development Organization (CRDO), specializes in musculoskeletal health. Offering a comprehensive range of services from preclinical research to post-marketing surveillance.
Founded in 2010, Artialis emerged from the University of Liege’s Bone and Cartilage Research Unit. With a strong foundation in scientific research, Artialis has grown into a trusted partner for pharmaceutical and biotech companies worldwide.
Over the past 14 years, Artialis has successfully completed 142 R&D projects, leveraging the combined expertise of its team, which boasts over 75 years of experience in the industry. This wealth of knowledge allows Artialis to provide tailored solutions and navigate the complexities of product development.
Driven by a commitment to client satisfaction, the company has achieved a remarkable 90% satisfaction rate.
Lear more: www.artialis.com
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
April 30, 2026
Applied Clinical Trials Online Payment experience—including how, when, and with what level of transparency sites are compensated—is rapidly emerging as a defining factor in the success of clinical trials. Once dismissed as a simple operational nuisance, payments are now recognized as a critical component for shaping site relationships and study outcomes. For years, sites had […]
April 30, 2026
Med City News Certain features, commonplace on most e-commerce platforms, can help transform clinical trial search databases. Digital databases for clinical trial searches have already changed healthcare accessibility, bringing critical information about clinical trials to the patients who need it – and to the physicians who care for them. But these databases are also enormous […]
April 30, 2026
Med City News LLMs bring great potential to help the healthcare industry center care around patients’ needs by improving communication, access, and engagement. However, LLMs also present significant challenges associated with privacy and bias that also must be considered. Large language models (LLMs) have generated buzz in the medical industry for their ability to pass […]